Angel Wings treat hole-in-the-heart youngster:
This article was originally published in Clinica
Executive Summary
Doctors at the Children's Hospital of Michigan in the US have used a new procedure, in which a set of tiny wire wings are inserted into the heart, to treat successfully a 15-year old boy with atrial septal defect. The Angel Wings device, made by Microvena and consisting of two square wire frames covered with polyester, is in Phase II trials. Doctors at 13 sites will compare the procedure, which takes around four to six hours to perform, with open heart surgery in around 200 patients over the next two years.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.